CME Group's Board of Directors Nominee Announcement
CME Group Inc., a leading force in the derivatives marketplace, has unveiled its slate of nominees for its board of directors. This announcement comes as the company gears up for its annual meeting, where shareholders will have the opportunity to elect new board members.
Proposed Candidates for Election
The board recommends that both Class A and Class B shareholders come together to elect a notable group of individuals to help guide CME Group's future. The nominees include:
- Terrence A. Duffy, 66, who serves as the Chairman and CEO of CME Group.
- Kathryn Benesh, 65, a CPA and Retired Partner at Deloitte.
- Timothy S. Bitsberger, 65, a former Managing Director and Portfolio Specialist at The TCW Group.
- Charles P. Carey, 71, who previously held the position of Vice Chairman at CME Group.
- Bryan T. Durkin, 64, Former President of CME Group.
- Harold Ford Jr., 54, Regional President at PNC Financial Services Group and a former member of Congress.
- Martin J. Gepsman, 72, an Independent Broker and Trader.
- Daniel G. Kaye, 70, a CPA and Retired Partner at Ernst & Young LLP.
- Phyllis M. Lockett, 59, Founder & Senior Advisor at LEAP Innovations, and CEO of LEAP-X.
- Deborah J. Lucas, 66, a Sloan Professor of Finance at the MIT Sloan School of Management.
- Rahael Seifu, 43, Director of Legal at Google LLC.
- William R. Shepard, 78, President and Founder of Shepard International, Inc.
- Howard J. Siegel, 68, an Independent Trader.
- Dennis A. Suskind, 82, Retired Partner at Goldman Sachs & Co. and Lead Director at CME Group.
Departing Directors
In an important shift, the 2025 annual meeting will see the retirement of three sitting board members: Larry G. Gerdes, Daniel R. Glickman, and Terry L. Savage. Their departure marks the end of a significant chapter in the company’s governance.
CME Group Chairman Terrence Duffy expressed gratitude towards the retiring directors, saying, "We want to thank our departing directors Larry, Dan, and Terry for their distinguished service on our Board. Their contributions have been invaluable to CME Group's success.”
Class B Shareholder Recommendations
The Nominating and Governance Committee has also put forward nominees for election by Class B shareholders. Here’s how the slate is structured:
Nominees for Class B-1 Shareholders
- William W. Hobert, 61, Managing Director and Founder of WH Trading LLC.
- Patrick J. Mulchrone, 67, an Independent Trader.
- Robert J. Tierney Jr., 49, Managing Member and Owner of Kore Trading LLC.
Nominees for Class B-2 Shareholders
- Patrick W. Maloney, 63, Independent Floor Broker.
- Liam Smith, 40, Chief Strategy Officer at Optiver.
Nominee for Class B-3 Shareholders
- Elizabeth A. Cook, 64, an Independent Broker and Trader.
CME Group: A Leader in Risk Management
As a premier derivatives marketplace, CME Group empowers clients to engage in futures, options, cash, and OTC trading, optimize their portfolios, and analyze critical data. Through its cutting-edge platform, CME Globex, the company provides access to a wide array of global benchmark products spanning major asset classes such as interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.
CME Group continues to be recognized for its contributions to risk management on a global scale, offering products that meet the diverse needs of market participants. Through CME Clearing, it also operates as one of the foremost central counterparty clearing providers.
Frequently Asked Questions
What is the purpose of CME Group's annual meeting?
The annual meeting allows shareholders to vote on board members and discuss important company matters.
Who are some key nominees for CME Group's board?
Key nominees include Terrence A. Duffy and Kathryn Benesh, among others.
What positions are the departing board members holding?
The departing board members are Larry G. Gerdes, Daniel R. Glickman, and Terry L. Savage.
How does CME Group support market participants?
CME Group supports market participants by providing diverse trading options and risk management solutions.
What is CME Group's role in the derivatives market?
CME Group acts as a leading marketplace, offering a wide range of benchmark products for trading and managing risk.
